Key points are not available for this paper at this time.
Design
Review
Risk stratification remains imprecise for long-term survival in unstable angina/NSTEMI; leaves open need for validated tools and targeted trials.
Although there have been advances in the management of unstable angina/non-ST segment elevation myocardial infarction syndromes, the rate of cardiovascular mortality after discharge is still unacceptably high. With many therapeutic options available, the clinician is challenged to identify the safest and most effective treatment for long term survival of each individual patient
No takes yet. Share an insight, caveat, or question.
Raffaele Bugiardini (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: